Plasma interleukin-6 and tumor necrosis factor-α can predict coronary endothelial dysfunction in hypertensive patients

Hypertension Research

Volumn 30, Issue 6, 2007, Pages 541-548

  Naya, Masanao ^a   Tsukamoto, Takahiro ^a,b   Morita, Koichi ^a   Katoh, Chietsugu ^a   Furumoto, Tomoo ^a   Fujii, Satoshi ^a   Tamaki, Nagara ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Date Red Cross Hospital   (Japan)

Author keywords

Coronary endothelial dysfunction; Hypertension; Interleukin 6; Positron emission tomography; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXYGEN 15; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY VASCULAR RESISTANCE; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; HEART MUSCLE BLOOD FLOW; HIGH RISK PATIENT; HUMAN; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; UNIVARIATE ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLD; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

EID: 34447573648     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.541     Document Type: Article

References (27)

1. Pepine CJ: Systemic hypertension and coronary artery disease. Am J Cardiol 1998; 82: 21H-24H.
2. Laine H, Raitakari OT, Niinikoski H, et al: Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 147-153.
3. Schindler TH, Nitzsche EU, Munzel T, et al: Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003; 42: 814-822.
4. Schindler TH, Nitzsche EU, Olschewski M, et al: Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors. Circulation 2004; 110: 1069-1075.
5. Kinugawa S, Post H, Kaminski PM, et al: Coronary microvascular endothelial stunning after acute pressure overload in the conscious dog is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase. Circulation 2003; 108: 2934-2940.
6. Hozawa A, Ebihara S, Ohmori K, et al: Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project. Hypertens Res 2004; 27: 557-561.
7. Okura Y, Takao M, Zhang B, et al: Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004; 27: 723-729.
8. Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
9. Schindler TH, Nitzsche EU, Schelbert HR, et al: Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005; 45: 1505-1512.
10. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
11. Schindler TH, Hornig B, Buser PT, et al: Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol 2003; 23: 495-501.
12. Halcox JP, Schenke WH, Zalos G, et al: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
13. Ridker PM, Rifai N, Stampfer MJ, et al: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.
14. Wassmann S, Stumpf M, Strehlow K, et al: Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 2004; 94: 534-541.
15. Ridker PM, Rifai N. Pfeffer M, et al: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-2153.
16. Kaufmann PA, Gnecchi-Ruscone T, Yap JT, et al: Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 1999; 40: 1848-1856.
17. Robertson D, Johnson GA, Robertson RM, et al: Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979; 59: 637-643.
18. Zeiher AM, Drexler H, Wollschlaeger H, et al: Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989; 14: 1181-1190.
19. Katoh C, Morita K, Shiga T, et al: Improvement of algorithm for quantification of regional myocardial blood flow using 15O-water with PET. J Nucl Med 2004; 45: 1908-1916.
20. Furuyama H, Odagawa Y, Katoh C, et al: Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation 2002; 105: 2878-2894.
21. Iwado Y, Yoshinaga K, Furuyama, H, et al: Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging 2002; 29: 984-990.
22. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
23. Sterpetti AV, Cucina A, Morena AR, et al: Shear stress increases the release of interleukin-1 and interleukin-6 by aortic endothelial cells. Surgery 1993; 114: 911-914.
24. Lee KW, Blann AD, Lip GY: Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 2006; 111: 302-308.
25. Lindmark E, Diderholm E, Wallentin L, et al: Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107-2113.
26. Picchi A, Gao X, Belmadani S, et al: Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006; 99: 69-77.
27. Bautista LE, Vera LM, Arenas IA, et al: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005; 19: 149-154.